Gene · 4938
Papers3,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Gene Expression in Human Upper Respiratory Tract Samples Identifies Antiviral Responses in Omicron SARS-CoV-2 Infection. | Genes (Basel) | 2026 | 42194954 | PubTator, text mining | PubMed |
| SARS-CoV-2 5'-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1). | J Biol Chem | 2026 | 42190814 | PubTator, text mining | PubMed |
| Mechanistic and preclinical evaluation of SIRT3 as a therapeutic target in melanoma. | J Derm Oncol | 2026 | 42146866 | PubTator, text mining | PubMed |
| Integrated immune, apoptotic and mitochondrial gene dysregulation in Long COVID and their association with symptom burden at 10 months post-infection. | Sci Rep | 2026 | 42141069 | PubTator, text mining | PubMed |
| Mpox virus D8L protein binds to STAT1 and inhibits its phosphorylation to antagonize IFN-induced signaling. | Cell Commun Signal | 2026 | 42135820 | PubTator, text mining | PubMed |
| SPRY domains encode ubiquitin ligase specificity for ZAP and RIG-I. | PLoS Pathog | 2026 | 42102160 | PubTator, text mining | PubMed |
| Biomarkers associated with Hashimoto's thyroiditis induced by viral infection: An integrative bioinformatics and machine learning. | J Transl Autoimmun | 2026 | 42089095 | PubTator, text mining | PubMed |
| The Enzymatic Mechanism of OAS: How Metal Ions and Quantum Effects Help Activate Innate Immunity. | ACS Omega | 2026 | 42077911 | PubTator, text mining | PubMed |
| Bifidobacteriumanimalis subsp. lactis BB-12 Primes Epithelial Antiviral Defenses and Restricts Influenza A Virus Replication in Human Intestinal Organoid-Derived Monolayers. | Microorganisms | 2026 | 42075148 | PubTator, text mining | PubMed |
| Human respiratory syncytial virus regulates the expression of interferon-stimulated genes through modulation of fibrillarin. | Front Cell Infect Microbiol | 2026 | 42064218 | PubTator, text mining | PubMed |
| Neomycin Exhibits Immunomodulatory and Antiviral Activity Against Influenza B Virus. | Viruses | 2026 | 42043233 | PubTator, text mining | PubMed |
| cGAS inhibitor IMSB301 modifies interferon signalling in peripheral mononuclear cells of SAMHD1 genetic interferonopathy in vitro. | Clin Transl Immunology | 2026 | 42016148 | PubTator, text mining | PubMed |
| Non-canonical proteolytic activation of RNase L by SARS-CoV-2 3CLpro offsets inactivation of OAS1 p46 antiviral signaling. | Cell Rep | 2026 | 42001419 | PubTator, text mining | PubMed |
| The Functional OAS1 rs10774671A>G Variant Is Associated with COVID-19 Susceptibility in Mexican Patients. | Int J Mol Sci | 2026 | 41977153 | PubTator, text mining | PubMed |
| SARS-CoV-2 5'-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1). | bioRxiv | 2026 | 41959085 | PubTator, text mining | PubMed |
| Artificial Intelligence in Bulk RNA-Seq: Challenges and Potential Solutions. | Comput Struct Biotechnol J | 2026 | 41939295 | PubTator, text mining | PubMed |
| Automated whole-blood detection of IFI27 and OAS1 mRNA for distinguishing active systemic lupus erythematosus. | Rheumatology (Oxford) | 2026 | 41936093 | PubTator, text mining | PubMed |
| Genetic Influences on Disease-Modifying Therapy Response in Multiple Sclerosis: Current Insights and Future Directions. | Balkan Med J | 2026 | 41918263 | PubTator, text mining | PubMed |
| Development of a progressive HIV-1-Like infection model in northern pig-tailed macaques using stHIV-1sv/G53D. | Emerg Microbes Infect | 2026 | 41914615 | PubTator, text mining | PubMed |
| Overexpression of OAS Genes in Severe COVID-19: A Cross-Sectional Study of Hospitalized Patients Infected with Delta and Omicron Variants. | J Clin Med | 2026 | 41899113 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4938/papers?page=2